Pizzighettone, Italy

Laura Anna Trespidi

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 4 EPO patents. Top assignee: Shire Biochem, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Anna Trespidi. Retrieved from https://idiyas.com/inventor/laura-anna-trespidi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Anna Trespidi: Innovator in Pharmaceutical Formulations

Introduction

Laura Anna Trespidi is a notable inventor based in Italy. She has made significant contributions to the field of pharmaceutical formulations. Her work focuses on innovative solutions that enhance the effectiveness of medications.

Latest Patents

Laura Anna Trespidi holds a patent for a pharmaceutical formulation comprising lanthanum compounds. This invention relates to a chewable lanthanum formulation that includes a pharmaceutically effective amount of a lanthanum compound and at least one chewable pharmaceutically acceptable excipient. The patent also describes a process for producing this formulation, which involves powder blending, compressing, and milling the materials to create a free-flowing mixture.

Career Highlights

Laura is currently associated with Shire Holdings AG, where she applies her expertise in pharmaceutical development. Her innovative approach to drug formulation has the potential to improve patient compliance and therapeutic outcomes.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Laura Anna Trespidi is a pioneering inventor whose work in pharmaceutical formulations demonstrates her commitment to advancing healthcare solutions. Her contributions are valuable in the ongoing quest for effective and patient-friendly medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…